From functional to microvascular abnormalities in early diabetic retinopathy

Diabetes/Metabolism Reviews

Volumn 13, Issue 1, 1997, Pages 15-35

  Ghirlanda, Giovanni ^b   Di Leo, Mauro A S ^b   Caputo, Salvatore ^b   Cercone, Stefania ^b   Greco, Aldo V ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Ist di Medicine Interna e Geriatria ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD FLOW; COLOR VISION; CONTRAST SENSITIVITY; DARK ADAPTATION; DIABETES MELLITUS; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; PERIMETRY; PRIORITY JOURNAL; REVIEW;

ACCLIMATIZATION; ANIMALS; CONTRAST SENSITIVITY; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; ELECTROPHYSIOLOGY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; RETINA; RETINAL VESSELS; VISUAL FIELDS;

EID: 0030994085     PISSN: 07424221     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0895(199703)13:1<15::AID-DMR176>3.0.CO;2-M     Document Type: Review

References (204)

1. Engerman RL, and Kern TS: Hyperglycemia as a cause of diabetic retinopathy. Metabolism 35 (Suppl. 1): 20-23, 1986.
2. Bresnick GH: Diabetic retinopathy viewed as a neurosensory disorder. Arch Ophthalmol 104: 989-990, 1986.
3. Cunha-Vaz JG and Maurice DM: The active transport of fluorescein by the retinal vessels and the retina. J Physiol (Lond) 191: 467-486, 1967.
4. Cunha-Vaz J, Faria De Abreu JR, Campos AJ, and Figo GM: Early breakdown of the blood retinal barrier in diabetes. Br J Ophthalmol 59: 649-656, 1975.
5. Waltman SR, Oestrich G, Krupin T, Hanish S, Ratzan S, Santiago JV, and Kilo C: Quantitative vitreous fluorophotometry: A sensitive technique for measuring early breakdown of the blood-retinal barrier in young diabetic patients. Diabetes 27: 85-87, 1978.
6. Krupin T, Waltman SR, Oestrich C, Santiago J, Ratzan S, Kilo C, and Becker B: Vitreous fluorophotometry in juvenile-onset diabetes mellitus. Arch Ophthalmol 96: 812-814, 1978.
7. Cunha-Vaz JG, Goldberg MF, Vygantes C, and Noth J: Early detection of retinal involvement in diabetes by vitreous fluorophotometry. Ophthalmology 86: 264-275, 1979.
8. White NH, Waltman SR, Krupin T, and Santiago JV: Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control. Diabetes 31: 80-85, 1982.
9. Kayazawa F: Ocular fluorophotometry in diabetic patients without apparent retinopathy. Ann Ophthalmol 16: 221-225, 1984.
10. Cunha-Vaz JG, Gray JR, Zeimer RC, Mota MC, Ishimoto BM, and Leite E: Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes 34: 53-59, 1985.
11. Zeimer RC, Blair NP, and Cunha-Vaz JG: Vitreous fluorophotometry for clinical research. I. Description and evaluation of a new fluorophotometer. Arch Ophthalmol 101: 1753-1756, 1983.
12. Zeimer RC, Blair NP, and Cunha-Vaz JG: Vitreous fluorophotometry for clinical research. II. Methodology of data acquisition and processing. Arch Ophthalmol 101: 1757-1761, 1983.
13. Krogsaa B, Lund-Andersen H, Mehlsen J, and Sestoft L: The blood-retinal barrier permeability to fluorescein in normal subjects and in juvenile diabetics without retinopathy. Acta Ophthalmol (Copenh) 64: 173-179, 1986.
14. Bursell SE, Delori FC, Yoshida A, Parker JS, Collas GD, and McMeel JW: Vitreous fluorophotometric evaluation of diabetics. Invest Ophthalmol Vis Sci 25: 703-710, 1984.
15. Kjaergaard JJ and Ohrt V: Ocular fluorophotometry in insulin treated diabetic patients with and without retinopathy. Int J Microcirc Clin Exp 2: 207-213, 1983.
16. Krogsaa B, Lund-Andersen H, Mehlsen J, Sestoft L, and Larsen J: The blood-retinal barrier permeability in diabetic patients. Acta Ophthalmol (Copenh) 59: 689-694, 1981.
17. Porta M, Townsend C, Glover GM, Nanson M, Alderson AR, McCraw A, and Kohner EM: Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia 20: 597-601, 1981.
18. Prager TC, Hsuan HC, Garcia CA, Anderson RE, Field JB, Orzeck EA, and Comstock JP: The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: Effect of vitreous abnormalities on the measurement. Invest Ophthalmol Vis Sci 24: 57-65, 1983.
19. Roy MS, Podgor MJ, Bungay P, Grunberger G, Carl J, and Ellis D: Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy. Retina 7: 170-176, 1987.
20. Chahal P, Fallon TJ, Jennings SJ, Chowienczyk PJ, and Kohner EM: Vitreus fluorophotometry in patients with no or minimal diabetic retinopathy. Diabetes Care 9: 134-139, 1986.
21. Waltman SR: Sequential vitreous fluorophotometry in diabetes mellitus: A five-year prospective study. Trans Am Ophthalmol Soc 82: 827-849, 1984.
22. Cunha-Vaz J, Leite E, Sousa JC, and De Abreu JR: Blood-retinal barrier permeability and its relation to progression of retinopathy in patients with type 2 diabetes: A four-year follow-up study. Graefes Arch Clin Exp Ophthalmol 231: 141-145, 1993.
23. Stur M, Reitner A, and Irsigler K: The correlation of results of vitreous fluorophotometry and fluorescein angiography in nonproliferative diabetic retinopathy. Retina 8: 50-54, 1988.
24. Benitez del Castillo JM, Castillo A, Garcia Sanchez J, Ruibal JL, Reverte F, and Ibarra JM: An 18-month vitreous fluorophotometric follow-up study in juvenile diabetics. Acta Ophthalmol 71: 651-656, 1993.
25. Van Gerven JMA, Boot JP, Lemkes HHPJ, and Van Best JA: Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy. Doc Ophthalmol 80: 183-188, 1992.
26. Dalgaard P, Barker VA, and Lund-Andersen H: Vitreous fluorophotometry: Mathematical analysis of the effect of peripheral leakage on axial scans. Invest Ophthalmol Vis Sci 30: 1522-1526, 1989.
27. McMillan DE: Rheological and related factors in diabetic retinopathy. In International Ophthalmology Clinics, Kohner EM, Ed. Little, Brown, Boston, 1978, p. 35.
28. L'Esperance FA Jr: The pathologic hemodynamics of diabetic retinopathy: A theory. Am J Ophthalmol 71: 251-260, 1971.
29. Kohner EM: The problems of retinal blood flow in diabetes. Diabetes 25 (Suppl. 2): 839-844, 1976.
30. Kohner EM, Hamilton AM, Saunders SJ, Sutcliffe BH, and Bulpitt CJ: The retinal blood flow in diabetes. Diabetologia 11: 27-33, 1975.
31. Cunha-Vaz JG, Fonseca JR, deAbreu JRF, and Lima JJP: Studies on retinal blood flow. II. Diabetic retinopathy. Arch Ophthalmol 96: 809-811, 1978.
32. Falck A, and Laatikainen L: Retinal vasodilation and hyperglycaemia in diabetic children and adolescents. Acta Ophthalmol Scand 73: 119-124, 1995.
33. Grunwald JE, Riva CE, Petrig BL, Brucker AJ, Schwartz SS, Braunstein SN, DuPont J, and Grunwald S: Strict control of glycaemia: Effect on blood flow in the large retinal vessels and in the macular microcirculation. Br J Ophthalmol 79: 735-741, 1995.
34. Atherton A, Hill DW, Keen H, Young S, and Edwards EJ: The effect of acute hyperglycemia on the retinal circulation in the human retina. Diabetologia 18: 233-237, 1980.
35. Fallon TJ, Chowienczyk P, and Kohner EM: Measurement of retinal blood flow in diabetes by the blue light entoptic phenomenon. Br J Ophthalmol 70: 43-48, 1986.
36. Riva CE, and Feke GT: Laser doppler velocimetry in the measurement of retinal blood flow. In The Biomedical Laser, Goldman L, Ed., Springer, New York, 1981, p. 135.
37. Feke GT, Tagawa H, Yoshida A, Goger DG, Weiter JJ, Buzney SM, and McMeel JW: Retinal circulation changes related to retinopathy progression in insulin-dependent diabetes mellitus. Ophthalmology 92: 1517-1522, 1985.
38. Grunwald JE, Riva CE, Sinclair SH, Brucker AJ, and Petrig BL: Laser doppler velocimetry study of retinal circulation in diabetes mellitus. Arch Ophthalmol 104: 991-996, 1986.
39. Patel V, Rassam S, Newsom R, Wiek J, and Kohner EM: Retinal blood flow in diabetic retinopathy. Br Med J 305: 678-683, 1992.
40. Grunwald JE, Riva CE, Baine J, and Brucker AJ: Total retinal volumetric blood flow rate in diabetic patients with poor glycaemic control. Invest Ophthalmol Vis Sci 33: 356-363, 1992.
41. Grunwald JE, Brucker AJ, Grunwald SE, and Riva CE: Retinal hemodynamics in proliferative diabetic retinopathy: A laser Doppler velocimetry study. Invest Ophthalmol Vis Sci 34: 66-71, 1993.
42. Grunwald JE, Brucker AJ, Schwartz SS, Branstein SN, Baker L, Petrig BL, and Riva CE: Diabetic glycemic control and retinal blood flow. Diabetes 39: 602-607, 1990.
43. Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, and Wolpert HA: Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no retinopathy. Invest Ophthalmol Vis Sci 37: 886-897, 1996.
44. Konno S, Feke GT, Yoshida A, Fujio N, Goger DG, and Buzney SM: Retinal blood flow changes in type I diabetes: A long-term follow-up study. Invest Ophthalmol Vis Sci 37: 1140-1148, 1996.
45. Kohner EM, Patel V, and Rassam SM: Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44: 603-607, 1995.
46. Johnson PC, and Wayland H: Regulation of blood flow in single capillaries. Am J Physiol 212: 1405-1415, 1967.
47. Nehls V, and Drenckhahn D: Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J Cell Biol 113: 147-154, 1991.
48. Kohner EM, Patel V, and Rassam SMB: Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44: 603-607, 1995.
49. Rassam SMB, Patel V, and Kohner EM: The effect of experimental hypertension on retinal autoregulation in humans: a mechanism for the progression of diabetic retinopathy. Exp Physiol 80: 53-68, 1995.
50. Grunwald JE, Riva CE, Bruckner AJ, Sinclair SH, and Petrig BL: Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology 91: 1447-1452, 1984.
51. Grunwald JE, Bruckner AJ, Petrig B, and Riva CE: Retinal blood flow regulation and the clinical response to panretinal photocoagulation. Ophthalmology 96: 1518-1522, 1989.
52. Simonsen SE: ERG in diabetics. In The Clinical Value of Electroretinography of the ISCERG Sympsosium, Ghent 1966. Karger, Basel, 1968, pp. 403-412.
53. Zanen J: Introduction a l'étude de dyschromatopsias retiniennes centrales asquises. Bull Soc Belge Opthalmol 103: 3-148, 1953.
54. Dubois-Poulsen A, Couchet P: Un cas de dyschromatopsie diabétique. Bull Soc Opthalmol France 4: 323-330, 1954.
55. Cox J: Colour vision defects acquired in diseases of the eye. Br J Physiol Opt 17: 195-216, 1960.
56. Verriest G: Further studies on acquired deficiency of color discrimination. J Opt Soc Am 53: 185-195, 1963.
57. Lakowski R, Aspinall PA, and Kinnear PR: Association between colour vision losses and diabetes mellitus. Ophthalmol Res 4: 145-159, 1972.
58. Tanabe S, Hukami K, and Ichikawa H: New pseudoisochromatic plates for acquired color vision defects. Doc Ophthalmol 39: 199-205, 1984.
59. Farnsworth D: The Farnsworth-Munsell 100 Hue and dichomatous tests for colour vision. J Opt Soc Am 33: 568-578, 1978.
60. Kinnear PR, Aspinall PA, and Lakowski R: The diabetic eye and colour vision. Trans Ophthalmol Soc UK 92: 69-78, 1972.
61. Aspinall PA, Kinnear PR, Duncan LJP, and Clarke BF: Prediction of diabetic retinopathy from clinical variables and color vision data. Diabetes Care 6: 144-148, 1983.
62. Bresnick GH, Condit RS, Palta M, Korth K, Groo A, and Syrjala S: Association of hue discrimination loss and diabetic retinopathy. Arch Ophthalmol 103: 1317-1324, 1985.
63. Roy MS, Gunkel RD, and Podgor MJ: Color vision defects in early diabetic retinopathy. Arch Ophthalmol 104: 225-228, 1986.
64. Zisman F, and Adams AJ: Spectral sensitivity of cone mechanisms in juvenile diabetics. Doc Ophthalmol 33: 127-131, 1982.
65. Adams AJ, Zisman F, Rodic R, and Cavender JC: Chromaticity and luminosity changes in glaucoma and diabetes. Doc Ophthalmol 33: 413-417, 1982.
66. Greenstein VC, Hood DC, Ritch R, Steinberger D, and Carr RE: S (blue) cone pathway vulnerability in retinis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci 30: 1732-1737, 1989.
67. Greenstein VC, Sarter B, Hood DC, Noble K, and Carr RE: Hue discrimination and S cone pathway sensitivity in early diabetic retinopathy. Invest Ophthalmol Vis Sci 31: 1008-1014, 1990.
68. Greenstein VC, Shapiro A, Zaidi Q, and Hood DC: Psychophysical evidence for post-receptoral sensitivity loss in diabetics. Invest Ophthalmol Vis Sci 33: 2781-2790, 1992.
69. Zaidi Q, Shapiro A, and Hood D: The effect of adaptation on the differential sensitivity of the S-cone color system. Vision Res 32: 1297-1318, 1992.
70. Elsner AE, Burns SA, Lobes LA, and Doft BH: Cone photopigment bleaching abnormalities in diabetes. Invest Ophthalmol Vis Sci 28: 718-724, 1987.
71. Schefrin B, Haegerstrom-Portnoy G, Adams A, Verdon W, and Hood D: Psychophysical testing of sites of disease action secondary to diabetes. Invest Ophthalmol Vis Sci 29 (Suppl.): 68, 1988.
72. Thompson PG, Howarth F, Taylor H, and Levy IS: Defective color vision in diabetics: A hazard to management. Br Med J i: 859-860, 1979.
73. Bresnick GH, Groo A, Palta M, and Korth K: Urinary glucose testing inaccuracies among diabetic patients: Effect of acquired color vision deficiency caused by diabetic retinopathy. Arch Ophthalmol 102: 1489-1496, 1984.
74. Sawicki PT, Karschny L, Stolpe V, Wolf E, and Berger M: Color discrimination and accuracy of blood glucose self-monitoring in type I diabetic patients. Diabetes Care 14: 135-137, 1991.
75. Barbur JL: Spatial frequency specific measurements and their use in clinical psychophysics. Clin Vision Sci 2: 225-233, 1988.
76. Ghafour MI, Fould WS, Allan D, and McClure E: Contrast sensitivity in diabetic subjects with and without retinopathy. Br J Ophthalmol 66: 492-495, 1982.
77. Howes SC, Caelli T, and Mitchell P: Contrast sensitivity in diabetics with retinopathy and cataract. Aust J Ophthalmol 10: 173-178, 1982.
78. Hyvärinen L, Laurinen P, and Rovamo J: Contrast sensitivity in evaluation of visual impairment due to diabetes. Acta Ophthalmol 61: 94-101, 1983.
79. Regan D, and Neima D: Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson's disease. Br J Ophthalmol 68: 885-889, 1984.
80. Sokol S, Moskowitz A, Skarf B, Evans R, Molitch M, and Senior B: Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol 103: 51-54, 1985.
81. Della Sala S, Bertoni G, Somazzi L, Stubbe F, and Wilkins AJ: Impaired contrast sensitivity in diabetic patients with and without retinopathy: A new technique for rapid assessment. Br J Ophthalmol 69: 136-142, 1985.
82. Marmor F: Contrast sensitivity versus visual acuity in retinal disease. Br J Ophthalmol 70: 553-559, 1986.
83. Kawasaki K, Yonemura K, Yokogawa Y, Saito N, and Kawakita S: Correlation between ERG oscillatory potential and psychophysical contrast sensitivity in diabetes. Doc Ophthalmol 64: 209-215, 1986.
84. Trick GL, Burde RM, Gordon MO, Santiago JV, and Kilo C: The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology 95: 693-698, 1988.
85. Nordmann JP, Guigui A, Laroche L, Denis P, and Saraux H: Sensibilité au contraste et diabète. Bull Soc Ophthalmol Fr 90: 465-469, 1990.
86. Corwin TR, and Richman JE: Three clinical tests of the spatial contrast sensitivity function: A comparison. Am J Optom Physiol Opt 63: 413-418, 1986.
87. Tweten S, Wall M, and Schwartz BD: A comparison of three clinical methods of spatial contrastsensitivity testing in normal subjects. Graefe's Clin Exp Ophthalmol 228: 24-27, 1990.
88. Di Leo MAS, Caputo S, Falsini B, Porciatti V, Minnella A, Greco AV, and Ghirlanda G: Nonselective loss of contrast sensitivity in visual system testing in early type 1 diabetes. Diabetes Care 15: 620-625, 1992.
89. Frost-Larsen K, and Larsen HW: Nyctometry, a new screening method for selection of patients with simple diabetic retinopathy who are at risk of developing proliferative retinopathy. Acta Ophthalmol 61: 353-361, 1983.
90. Frost-Larsen K, Larsen HW, and Simonsen SE: Oscillatory potential and nyctometry in insulindependent diabetics. Acta Ophthalmol 58: 879-888, 1980.
91. Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, and the Steno Study Group: Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet i: 200-204, 1983.
92. Lauritzen T, Frost-Larsen K, Larsen HW, Delbridge L, Reeve T, and Turtle JR: Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 34 (Suppl. 3): 74-79, 1985.
93. Brinchmann-Hansen O, Dahl-Jørgensen K, Hansen KF, and Sandvik L: Oscillatory potentials, macular recovery time, and diabetic retinopathy through 3 years of intensified insulin treatment. Ophthalmology 95: 1358-1366, 1988.
94. Brinchmann-Hansen O, Dahl-Jørgensen K, Hansen KF, and Sandvik L: Macular recovery time, diabetic retinopathy, and clinical variables after 7 years of improved glycemic control. Acta Ophthalmol 70: 235-242, 1992.
95. Frost-Larsen K, and Larsen HW: Nyctometry - A new screening method for selection of patients with simple diabetic retinopathy who are at risk of developing proliferative diabetic retinopathy: Results of a 5-year follow-up. Acta Ophthalmol 173 (Suppl.): 39-47, 1985.
96. Frost-Larsen K, Lund-Andersen C, and Starup K: Macular recovery during onset and development of diabetic retinopathy in childhood and adolescence. Acta Ophthalmol 67: 401-404, 1989.
97. Frost-Larsen K, Christiansen JS, Lauritzen T, and Parving HH: The effect of short-term near-normal blood glucose control on oscillatory potential and macular recovery time in insulindependent diabetic patients with long-standing metabolic dysregulation. Acta Ophthalmol 67: 405-408, 1989.
98. Midena E, Segato T, Giuliani M, and Zucchetto M: Macular recovery function (nyctometry) in diabetics without and with early retinopathy. Br J Ophthalmol 74; 106-108, 1990.
99. Brinchmann-Hansen O, Dahl-Jørgensen K, Hansen KF, and Sandvik L: Blood glucose concentration and progression of diabetic retinopathy: The seven year results of the Oslo study. Br Med J 304: 19-22, 1992.
100. Federman JL, and Lloyd J: Automed static perimetry to evaluate diabetic retinopathy. Trans Am Ophthalmol Soc 82: 358-370, 1984.
101. Bell JA, and Feldon SE: Retinal microangiopathy: Correlation of OCTOPUS perimetry with fluorescein angiography. Arch Ophthalmol 102: 1294-1298, 1984.
102. Bek T: Localized scotomata and types of vascular occlusion in diabetic retinopathy. Acta Ophthalmol 69: 11-18, 1991.
103. Bek T, and Lund-Andersen H: Localised bloodretinal barrier leakage and retinal light sensitivity in diabetic retinopathy. Br J Ophthalmol 74: 388-392, 1990.
104. Cunha-Vaz J, Faria De Abreu JR, Campos AJ, and Figo GM: Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol 59: 649-656, 1975.
105. Wallow IHL: Posterior and anterior permeability defects? Morphologic observations on streptozocin-treated rats. Invest Ophthalmol Vis Sci 24: 1259-1268, 1983.
106. Grimes PA: Fluorescein distribution in retinas of normal and diabetic rats. Exp Eye Res 41: 227-238, 1985.
107. Chahal PS, Fallon T, Jennings SJ, Chowienczyk PJ, and Kohner EM: Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy. Diabetes Care 9: 134-139, 1986.
108. Hardy KJ, Lipton J, O Scale M, Scarpello JBH, and Foster DH: Diabetes and retinal function. Br J Ophthalmol 75: 191, 1991.
109. Kjaergaard JJ: Fluorophotometric studies of twenty-nine healthy subjects. Graefe's Clin Exp Ophthalmol 222: 267-268, 1985.
110. Bek T, and Lund-Andersen H: Cotton wool spots and retinal light sensitivity in diabetic retinopathy. Br J Ophthalmol 75: 13-17, 1991.
111. Bek T: Coexistence of localised scotomata and neovascolarizations in proliferative diabetic retinopathy. Acta Ophthalmol 68: 421-427, 1990.
112. Fichsel N: Visually evoked potentials in diabetic children. In Pediatric Adolescent Endocrinology, Vol.2, Laron Z., Ed., Karger, Basel, 1977, pp. 182-186.
113. Yamazaki H, Adachi-Usami A, and Chiba J: Contrast thresholds of diabetic patients determined by VECP and psychophysical measurements. Acta Ophthalmol 60: 368-392, 1982.
114. Puvanendran K, Devathasan G, and Wong PK: Visual evoked responses in diabetes. J Neurol Neurosurg Psychiatry 46: 643-647, 1983.
115. Cirillo D, Gonfiantini E, De Grandis D, Bongiovanni L, Robert JJ, and Pinelli L: Visual evoked potentials in diabetic children and adolescents. Diabetes Care 7: 273-275, 1984.
116. Pozzessere G, Rizzo PA, Valle E, Mollica MA, Meccia A, Morano S, Di Mario U, Andreani D, and Morocutti C: Early detection of neurological involvement in IDDM and NIDDM. Diabetes Care 11: 473-480, 1988.
117. Pozzessere G, Rizzo PA, Valle E, Mollica MA, Sanarelli L, Morano S, Pietravalle P, Di Mario U, and Morocutti C: A longitudinal study of multimodal evoked potentials in diabetes mellitus. Diabetes Res Clin Exp 10: 17-20, 1989.
118. Collier A, and Mitchell JD: Visual evoked potentials and contrast sensitivity function in diabetic retinopathy. Br Med J 291: 248, 1985.
119. Ponte F, Anastasi M, Lauricella M, and Bompiani GD: Optic pathway conduction in insulindependent diabetics. Doc Ophthalmol 63: 313-319, 1986.
120. Comi G, Martinelli V, Galardi G, Medaglini S, Poggi A, Beccaria L, Meschi F, and Floris D'Arcais A: Visual evoked 'potentials in diabetic teenagers: influence of metabolic control and relationship with peripheral neuropathy. Meth Pediatr Syst Ophthalmol 9: 85-87, 1986.
121. Lovasik JV, and Spafford MM: An electrophysiological investigation of visual function in juvenile insulin-dependent diabetes mellitus. Am J Optom Physiol Opt 65: 236-253, 1988.
122. Algan M, Ziegler O, Gehin P, Got I, Raspiller A, Weber M, Genton P, Saudax E, and Drouin P: Visual evoked potentials in diabetic patients. Diabetes Care 12: 227-229, 1989.
123. Martinelli V, Filippi M, Meschi F, Pozza G, Canal N, and Comi GC: Electrophysiological study of optic pathways in insulin dependent diabetes mellitus. Clin Vision Sci 6: 437-443, 1991.
124. Reske-Nielsen E, Lundbaek K, and Rafaelsen OJ: Pathological changes in the central and peripheral nervous system of young long-term diabetics. I. Diabetic encephalopathy. Diabetologia 1: 233-241, 1965.
125. Comi GC, Martinelli V, Galardi G, Medaglini S, Beccaria L, Meschi F, Rosti L, Bressani N, and Chiumello G: Evaluation of central nervous conduction by visual evoked potentials in insulin-dependent diabetic children: Metabolic and clinical correlation. Acta Diabetol Lat 24: 157-162, 1987.
126. Ziegler O, Guerci B, Algan M, Lochamp P, Weber M, and Drouin P: Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control. Diabetes Care 17: 1141-1147, 1994.
127. Francois J, and Derouck A: L'electroretinographie dans la retinopathie diabétique et dans la retinopathie hypertensive. Acta Ophthalmol 32: 391-104, 1954.
128. Karpe G, Kornerup T, and Wulfing B: The clinical electroretinogram. VIII. The electroretinogram in diabetic retinopathy. Acta Ophthalmol 32: 281-291, 1958.
129. Gjötterberg M: The electroretinogram in diabetic retinopathy: A clinical study and critical survey. Acta Ophthalmol 52: 521-533, 1974.
130. Yonemura D, Aoki T, and Tsuzuki K: Electroretinogram in diabetic retinopathy. Arch Ophthalmol 68: 19-24, 1962.
131. Simonsen SE: Electroretinographic study of diabetics: Preliminary report. Acta Ophthalmol 43: 841-843, 1965.
132. Simonsen SE: Prognostic value of ERG (oscillatory potential) in juvenile diabetics. Acta Ophthalmol 123: 223-224, 1975.
133. Simonsen SE: The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Metab Pediatr Syst Ophthalmol 5: 55-61, 1981.
134. Bresnick GH, Korth K, Groo A, and Palta M: Electroretinographic oscillatory potentials predict progression of diabetic retinopathy: Preliminary report. Arch Ophthalmol 102: 1307-1311, 1984.
135. Bresnick GH, and Palta M: Predicting progression to severe proliferative diabetic retinopathy. Arch Ophthalmol 105: 810-814, 1987.
136. Bresnick GH, and Palta M: Temporal aspects of the electroretinogram in diabetic retinopathy. Arch Ophthalmol 105: 660-664, 1987.
137. Kawasaki K, Yonemura K, Yokogawa Y, Saito N, and Kawakita S: Correlation between ERG oscillatory potential and psychophysical contrast sensitivity in diabetes. Doc Ophthalmol 64: 209-215, 1986.
138. Yoshida A, Nakamura K, and Kojima M: Study on the retinal function in early diabetic retinopathy. Comparison of ERG oscillatory potentials and vitreous fluorophotometry. Acta Soc Ophthalmol Jpn 90 (Suppl.): 114, 1986.
139. Shirao Y, Okumura T, Ohta T, and Kawasaki K: Clinical importance of electroretinographic oscillatory potentials in early detection and objective evaluation for diabetic retinopathy. Clin Vision Sci 6: 445-450, 1991.
140. Uccioli L, Parisi V, Monticone G, Parisi L, Durola L, Pernini C, Neuschuler R, Bucci M, and Menzinger G: Electrophysiological assessment of visual function in newly-diagnosed IDDM patients. Diabetologia 38: 804-808, 1995.
141. Riggs LA, Johnson EP, and Schick AMC: Electrical responses of the human eye to moving stimulus patterns. Science 144: 567, 1964.
142. Maffei L, and Fiorentini A: Electroretinographic responses alternating gratings before and after section of the optic nerve. Science 211: 953-955, 1981.
143. Arden GB, Vaegan and Hogg CR: Clinical and experimental evidence that the pattern electroretinogram (PERG) is generated in more proximal retinal layers than the focal electroretinogram (FERG). Ann NY Acad Sci 388: 580-601, 1982.
144. Harrison JM, O'Connor PS, Young SL, Kincaid M, and Bentley R: The pattern ERG in man, following surgical resection of the optic nerve. Invest Ophthalmol Vis Sci 28: 492-499, 1987.
145. Hess RF, and Baker CJ: Human pattern-evoked electroretinogram. J Neurophysiol 51: 939-951, 1984.
146. Tobimatsu S, Celesia GG, Cone SB, and Gurjati M: Electroretinograms to checkerboard pattern reversal in cats: Physiological characteristics and effect of retrograde degeneration of ganglion cells. Electroencephalogr Clin Neurophysiol 73: 344-352, 1989.
147. Berardi N, Domenici L, Gravina A, and Maffei L: Pattern ERG in rats following section of the optic nerve. Exp Brain Res 79: 539-546, 1990.
148. Maffei L, and Fiorentini A: Generator sources of the pattern ERG in man and animals. In Frontiers in Clinical Neuroscience, Vol III, Cracco RQ and Bodis-Wollner I, Eds. Alan R. Liss, New York, 1986, pp. 101-116.
149. Wanger P, and Persson HS: Early diagnosis of retinal changes in diabetes: A comparison between electroretinography and retinal biomicroscopy. Acta Ophthalmol 63: 716-720, 1985.
150. Arden GB, Hamilton AMP, Wilson-Holt J, Ryan S, Yudkin JS, and Kurtz A: Pattern electroretinogram becomes abnormal when background diabetic retinopathy deteriorates to a preproliferative stage: Possible use as a screening test. Br J Ophthalmol 70: 330-335, 1986.
151. Coupland SG: A comparison of oscillatory potential and pattern electroretinogram measures in diabetic retinopathy. Doc Ophthalmol 66: 207-218, 1987.
152. Ryan S, and Arden GB: Electrophysiological discrimination between retinal and optic nerve disorders. Doc Ophthalmol 68: 247-255, 1988.
153. Boschi MC, Frosini R, Mencucci R, and Sodi A: The influence of early diabetes on the pattern electroretinogram. Doc Ophthalmol 71: 369-374, 1989.
154. Juen S, and Kieselbach GF: Electrophysiological changes in juvenile diabetics without retinopathy. Arch Ophthalmol 108: 372-375, 1990.
155. Prager TC, Garcia CA, Mincher CA, Mishra J, and Chu HH: The pattern electroretinogram in diabetes. Am J Ophthalmol 109: 279-284, 1990.
156. Trick GL: Pattern evoked retinal and cortical potentials in diabetic patients. Clin Vision Sci 6: 209-217, 1991.
157. Fadda A, Falsini B, Neroni M, and Porciatti V: Development of a personal computer software for a visual electrophysiology laboratory. Comput Methods Programs Biomed 28: 45-50, 1989.
158. Falsini B, Porciatti V, Scalia G, Caputo S, Minnella A, Di Leo MAS, and Ghirlanda G: Steadystate pattern electroretinogram in insulin-dependent diabetics with no or minimal retinopathy. Doc Ophthalmol 73: 193-200, 1989.
159. Caputo S, Di Leo MAS, Falsini B, Ghirlanda G, Porciatti V, Minella A, and Greco AV: Evidence for early impairment of macular function with pattern electroretinogram in type I diabetic patients. Diabetes Care 13: 412-418, 1990.
160. Boycott BB, and Wässle H: The morphological types of ganglion cells of the domestic cat's retina. J Physiol (Lond) 240: 397-419, 1974.
161. De Monasterio FM: Properties of concentrically organized X and Y ganglion cells of the retina of macaques. J Neurophysiol 41: 1394-1417, 1978.
162. Di Leo MAS, Falsini B, Caputo S, Ghirlanda G, Porciatti V, and Greco AV: Spatial frequencyselective losses with pattern electroretinogram in type 1 (insulin-dependent) diabetic patients without retinopathy. Diabetologia 33: 726-730, 1990.
163. Hess RF, and Baker CJ: Human pattern-evoked electroretinogram. J Neurophysiol 51: 939-951, 1984.
164. Porciatti V: Non-linearities in the focal ERG evoked by pattern and uniform-field stimulation: Their variation in retinal and optic nerve dysfunction. Invest Ophthalmol Vis Sci 28: 1306-1313, 1987.
165. Porciatti V, Falsini B, Fadda A, and Bolzani R: Steady-state analysis of the focal ERG to pattern and flicker: Relationship between ERG components and retinal pathology. Clin Vision Sci 4: 323-332, 1989.
166. Zrenner E, Baker C, Hess RF, and Olsen BT: Die Lokalisation elektroretinographischer Antworten auf Muster Umkehrreize und Helligkeitsreize in einzelnen Schichten der Primatennetzhaut. Forsch Ophthalmol 84: 491-495, 1987.
167. Baker CL, Hess RF, Olsen BT, and Zrenner E: Current source density analysis of linear and non-linear components of the primate electroretinogram. J Physiol (Lond) 407: 155-176, 1988.
168. Ghirlanda G, Di Leo MAS, Caputo S, Falsini B, Porciatti V, Marietti G, and Greco AV: Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM. Diabetes 40: 1122-1127, 1991.
169. Di Leo MAS, Caputo S, Falsini B, Porciatti V, Greco AV, and Ghirlanda G: Presence and further development of retinal dysfunction after 3-year follow up in IDDM patients without angiographically documented vasculopathy. Diabetologia 37: 911-916, 1994.
170. Gabbay K: The sorbitol pathway and the complications of diabetes. N Engl J Med 288: 831-836, 1973.
171. Kador PF, and Kinoshita JH: Role of aldose reductase in the development of diabetes-associated complications. Am J Med 79 (Suppl. 5A): 8-12, 1985.
172. Van den Enden MK, Nyengaard JR, Ostrow E, Burgan JH, and Williamson JR: Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism: Implications for diabetic retinopathy. Invest Ophthalmol Vis Sci 36: 1675-1685, 1995.
173. Greene DA, Lattimer SA, and Sima AAF: Sorbitol, phosphoinositides, and sodium-potassium ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599-606, 1987.
174. Akagi Y, Yajima Y, Kador PF, Kuwabara T, and Kinoshita JH: Localization of aldose reductase in the human eye. Diabetes 33: 562-566, 1984.
175. Li W, Khatami M, and Rockey JH: The effects of glucose and an aldose reductase inhibitor on the sorbitol content and collagen synthesis of bovine retinal capillary perycetes in culture. Exp Eye Res 40: 439-444, 1985.
176. Frank RN: Aldose reductase activity and basement membrane thickening. Metabolism 35: 35-40, 1986.
177. Kern TS, and Engerman RL: Distribution of aldose reductase in ocular tissues. Exp Eye Res 33: 175-182, 1981.
178. Chakrabarti S, and Sima AAF: Pathogenetic heterogeneity in retinal capillary basement membrane thickening in the diabetic BB-rat. Diabetologia 30: 966-968, 1987.
179. Chakrabarti S, Sima AAF, Nakajima S, Yagihashi S, and Greene DA: Aldose reductase in the BB-rat: Isolation, immunological identification and localization in the retina and peripheral nerve. Diabetologia 30: 244-251, 1987.
180. MacGregor LC, Rosecan LR, Laties AM, and Matschinsky FM: Altered retinal metabolism in diabetes. I. Microanalysis of lipid, glucose, sorbitol, and myo-inositol in the choroid and in the individual layers of the rabbit retina. J Biol Chem 261: 4046-4051, 1986.
181. MacGregor LC, and Matschinsky FM: Altered retinal metabolism in diabetes. II. Measurement of sodium-potassium ATPase and total sodium and potassium in the individual retinal layers. J Biol Chem 261: 4052-4058, 1986.
182. Sredy J, Sawicki DR, and Notrest RR: Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: Effect of dietary galactose withdrawal or tolrestat intervention therapy. J Diab Compl 5: 42-47, 1991.
183. Sima AAF, Zhang WH, Cherian PV, and Chakrabarti S: Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat. Diabetologia 35: 602-607, 1992.
184. Vinores SA, Campochiaro PA, Williams EH, May E, Green WR, and Sorenson RL: Aldose reductase expression in human diabetic retina and retinal pigment epithelium. Diabetes 37: 1658-1664, 1988.
185. MacGregor LC, and Matschinsky FM: Treatment with aldose reductase inhibitor or with myoinositol arrests deterioration of the electroretinogram of diabetic rats. J Clin Invest 76: 887-889, 1985.
186. Oakley B, and Green DG: Correlation of light-induced changes in retinal extracellular potassium concentration with c-wave of the electroretinogram. J Neurophysiol 39: 1117-1133, 1976.
187. Engerman RL, and Kern TS: Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36: 808-812, 1987.
188. Cryer PE, Binder C, Bolli GB, Cherrington AD, Gale EAM, Gerich JE, and Sherwin RS: Hypoglycemia in IDDM. Diabetes 38: 1193-1199, 1989.
189. Frier BM, and Hilsted J: Does hypoglycaemia aggravate the complications of diabetes? Lancet ii: 1175-1177, 1985.
190. Amiel SA, Tamborlane WV, Saccà L, and Sherwin RS: Hypoglycemia and glucose counterregulation in normal and insulin-dependent diabetic subjects. Diabetes Metab Rev 4: 71-89, 1988.
191. Meyer JS, and Portnoy HD: Localized cerebral hypoglycemia simulating stroke: A clinical and experimental study. Neurology 8: 601-614, 1958.
192. Sidenius P, and Jakobsen J: Peripheral neuropathy in rats induced by insulin treatment. Diabetes 32: 383-386, 1983.
193. McCallum KNC, Sharma AK, Blanchard DS, Stribling D, Mirrlees DJ, Duguid IGM, and Thomas PK: The effect of continuous subcutaneous insulin infusion therapy on morphological and biochemical abnormalities of peripheral nerves in experimental diabetes. J Neurol Sci 74: 55-67, 1986.
194. Potter CG, Sharma AK, Farber MO, and Peterson R: Hypoglycemic neuropathy in experimental diabetes. J Neurol Sci 88: 293-301, 1988.
195. Holmes CS, Hayford JT, Gonzales JL, and Weydert JA: A survey of cognitive function at different glucose levels in diabetic persons. Diabetes Care 6: 180-185, 1983.
196. Herold KC, Polonsky KS, Cohen RM, Levy J, and Douglas F: Variable deterioration in cortical function during insulin-induced hypoglycemia. Diabetes 34: 677-685, 1985.
197. Pramming S, Thorsteinsson B, Theilgaard A, Pinner EM, and Binder C: Cognitive function during hypoglycemia in Type 1 diabetes mellitus. Br Med J 292: 647-650, 1986.
198. Huffman RG, Speelman DJ, Hinnen DA, Conley KL, Guthrie RA, and Knapp RK: Changes in cortical functioning with acute hypoglycemia and hyperglycemia in type 1 diabetes. Diabetes Care 12: 193-197, 1989.
199. Tallroth G, Lindgren M, Stenberg G, Rosen I, and Agardh C-D: Neurophysiological changes during insulin-induced hypoglycemia and in the recovery period following glucose infusion in Type 1 (insulin-dependent) diabetes mellitus and in normal man. Diabetologia 33: 319-323, 1990.
200. Harrad RA, Cockram CS, Plumb AP, Stone S, Fenwick P, and Sönksen PH: The effect of hypoglycemia on visual function: A clinical and electrophysiological study. Clin Sci 69: 673-679, 1985.
201. Törnquist P, and Aim A: Retinal and choroidal contribution to retinal metabolism in vivo: A study in pigs. Acta Physiol Scand 106: 425-430, 1979.
202. Törnquist P, Alm A, and Bill A: Studies on ocular blood flow and retinal capillary permeability to sodium in pigs. Acta Physiol Scand 106: 343-350, 1979.
203. Skrandies W, and Heinrich H: Differential effects of mild hypoglycemia on proximal and distal retinal structures in man as revealed by electroretinography. Neurosci Lett 134: 165-168, 1992.
204. Macaluso C, Onoe S, and Niemeyer G: Changes in glucose level affect rod function more than cone function in the isolated, perfused cat eye. Invest Ophthalmol Vis Sci 33: 2798-2808, 1992.